title: Role of a genetic polymorphism in the corticotropin-releasing factor receptor 1 gene in alcohol drinking and seeking behaviors of marchigian sardinian alcohol-preferring rats.
abstract: Marchigian Sardinian alcohol-preferring (msP) rats exhibit innate preference for alcohol, are highly sensitive to stress and stress-induced alcohol seeking. Genetic analysis showed that over-expression of the corticotropin-releasing factor (CRF) system of msP rats is correlated with the presence of two single nucleotide polymorphisms (SNPs) occurring in the promoter region (position -1836 and -2097) of the CRF1 receptor (CRF1-R) gene. Here we examined whether these point mutations were associated to the innate alcohol preference, stress-induced drinking, and seeking. We have recently re-derived the msP rats to obtain two distinct lines carrying the wild type (GG) and the point mutations (AA), respectively. The phenotypic characteristics of these two lines were compared with those of unselected Wistar rats. Both AA and GG rats showed similar patterns of voluntary alcohol intake and preference. Similarly, the pharmacological stressor yohimbine (0.0, 0.625, 1.25, and 2.5 mg/kg) elicited increased operant alcohol self-administration under fixed and progressive ratio reinforcement schedules in all three lines. Following extinction, yohimbine (0.0, 0.625, 1.25, and 2.5 mg/kg) significantly reinstated alcohol seeking in the three groups. However, at the highest dose this effect was no longer evident in AA rats. Treatment with the CRF1-R antagonist antalarmin (0, 5, 10, and 20 mg/kg) significantly reduced alcohol-reinforced lever pressing in the AA line (10 and 20 mg/kg) while a weaker or no effect was observed in the Wistar and the GG group, respectively. Finally, antalarmin significantly reduced yohimbine-induced increase in alcohol drinking in all three groups. In conclusion, these specific SNPs in the CRF1-R gene do not seem to play a primary role in the expression of the msP excessive drinking phenotype or stress-induced drinking but may be associated with a decreased threshold for stress-induced alcohol seeking and an increased sensitivity to the effects of pharmacological blockade of CRF1-R on alcohol drinking.
authors: Pharmacology Unit, School of Pharmacy, University of Camerino Camerino, Italy.
authors: Lydia O
authors: LO
authors: Ayanwuyi
authors: Francisca
authors: F
authors: Carvajal
authors: Jose M
authors: JM
authors: Lerma-Cabrera
authors: Esi
authors: E
authors: Domi
authors: Karl
authors: K
authors: Björk
authors: Massimo
authors: M
authors: Ubaldi
authors: Markus
authors: M
authors: Heilig
authors: Marisa
authors: M
authors: Roberto
authors: Roberto
authors: R
authors: Ciccocioppo
authors: Andrea
authors: A
authors: Cippitelli
keywords: CRF; SNP; msP; relapse; self-administration; yohimbine
references: J Neurosci. 1995 Aug;15(8):5439-47
references: 7643193
references: Neuroscience. 1988 Dec;27(3):897-904
references: 3252176
references: Psychopharmacologia. 1961;2:93-106
references: 13715444
references: Mol Psychiatry. 2011 Aug;16(8):809-17
references: 20479755
references: Pharmacol Biochem Behav. 2002 May;72(1-2):213-20
references: 11900791
references: Trends Neurosci. 2007 Aug;30(8):399-406
references: 17629579
references: Psychopharmacology (Berl). 2010 Sep;211(4):367-75
references: 20628734
references: Neuropsychopharmacology. 2010 May;35(6):1241-52
references: 20130533
references: Psychopharmacology (Berl). 2005 May;179(2):366-73
references: 15551068
references: Res Publ Assoc Res Nerv Ment Dis. 1992;70:231-52
references: 1535933
references: Alcohol. 2009 Nov;43(7):491-8
references: 19913192
references: Endocrinology. 1996 Dec;137(12):5747-50
references: 8940412
references: Science. 1982 Mar 12;215(4538):1394-6
references: 6278591
references: Pharmacol Biochem Behav. 2012 Sep;102(3):400-6
references: 22705492
references: Psychopharmacology (Berl). 2005 Apr;178(4):367-80
references: 15765253
references: Mol Psychiatry. 2006 Jun;11(6):594-602
references: 16550213
references: Psychopharmacology (Berl). 2007 Dec;195(3):345-55
references: 17705061
references: Drug Alcohol Depend. 2013 Mar 1;128(3):175-86
references: 23294766
references: Psychopharmacology (Berl). 2003 Jul;168(1-2):3-20
references: 12402102
references: Neuropsychopharmacology. 2005 Sep;30(9):1662-9
references: 15726114
references: Psychoneuroendocrinology. 2010 Jul;35(6):887-95
references: 20036073
references: Pharmacol Rep. 2012;64(2):449-53
references: 22661198
references: Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15236-41
references: 17015825
references: Psychopharmacology (Berl). 2010 Feb;208(3):417-26
references: 20012021
references: Nat Rev Neurosci. 2011 Oct 20;12(11):670-84
references: 22011682
references: Arch Gen Psychiatry. 1981 Aug;38(8):861-8
references: 7259422
references: J Neurosci. 2007 Mar 7;27(10):2718-26
references: 17344409
references: Pharmacol Biochem Behav. 2012 Jan;100(3):522-9
references: 22036774
references: Neuroscience. 2006;138(1):235-43
references: 16359808
references: PLoS One. 2008;3(10):e3620
references: 18974851
references: FASEB J. 2002 Jan;16(1):27-35
references: 11772933
references: Alcohol Clin Exp Res. 1985 Dec;9(6):475-92
references: 2936265
references: Psychopharmacology (Berl). 2010 Oct;212(3):431-9
references: 20676608
references: J Pharmacol Exp Ther. 2007 Dec;323(3):846-54
references: 17855476
references: J Neurosci. 2006 Nov 1;26(44):11324-32
references: 17079660
references: Eur J Neurosci. 2007 Jul;26(2):476-86
references: 17650118
references: Neuropharmacology. 2007 Dec;53(8):958-66
references: 17976662
references: Psychopharmacology (Berl). 2006 Dec;189(2):175-86
references: 17047935
references: Alcohol Clin Exp Res. 2004 Nov;28(11):1676-82
references: 15547454
references: Psychopharmacology (Berl). 2001 Dec;158(4):374-81
references: 11797058
references: Biol Psychiatry. 2010 May 1;67(9):831-9
references: 20060104
references: FASEB J. 2008 Jul;22(7):2113; author reply 2113-4
references: 18593720
references: Neuropsychopharmacology. 2003 Aug;28(8):1546-52
references: 12813472
references: Neuropsychopharmacology. 2011 May;36(6):1178-86
references: 21289601
references: Pharmacol Biochem Behav. 2007 Apr;86(4):813-21
references: 17482248
references: Nat Neurosci. 2005 Nov;8(11):1471-80
references: 16251990
references: Physiol Behav. 1995 Jun;57(6):1181-5
references: 7652041
references: Psychopharmacology (Berl). 2001 Dec;158(4):343-59
references: 11797055
references: J Neurosci. 1997 Apr 1;17(7):2605-14
references: 9065520
references: Pharmacol Ther. 2011 Feb;129(2):149-71
references: 20951730
references: Psychopharmacology (Berl). 2008 Jul;198(4):449-60
references: 18446329
references: Pharmacol Rev. 2001 Jun;53(2):209-43
references: 11356984
references: Alcohol Clin Exp Res. 2008 Feb;32(2):259-65
references: 18162072
references: J Neurosci. 1998 Jul 15;18(14):5529-36
references: 9651233
references: Neuropsychopharmacology. 2006 Oct;31(10):2188-96
references: 16341025
references: Addict Biol. 2007 Mar;12(1):30-4
references: 17407495
references: Alcohol Clin Exp Res. 2008 Sep;32(9):1535-42
references: 18631323
references: Am J Addict. 2012 Jul-Aug;21(4):343-7
references: 22691013
references: Curr Top Behav Neurosci. 2013;13:251-69
references: 22328453
references: Biol Psychiatry. 2007 Jan 1;61(1):78-86
references: 16876134
references: Alcohol Clin Exp Res. 2011 Jan;35(1):166-74
references: 21039637
references: Psychopharmacology (Berl). 1999 May;144(2):151-7
references: 10394996
references: Alcohol Clin Exp Res. 1991 Jun;15(3):438-59
references: 1898494
references: Psychiatr Clin North Am. 1999 Jun;22(2):289-99, viii
references: 10385934
references: Alcohol Alcohol Suppl. 1991;1:121-4
references: 1845526
references: Pharmacol Biochem Behav. 1997 Jul;57(3):441-7
references: 9218268
references: Biol Psychiatry. 2008 Jan 15;63(2):139-45
references: 17585886
references: Addict Biol. 2006 Sep;11(3-4):339-55
references: 16961763
references: Synapse. 1996 May;23(1):39-51
references: 8723134
references: Biol Psychiatry. 2011 Apr 1;69(7):642-9
references: 21276964
references: Synapse. 1996 May;23(1):28-38
references: 8723133
references: Pharmacol Ther. 2005 Oct;108(1):86-93
references: 16026844
references: Brain Res. 2010 Feb 16;1314:3-14
references: 19912996
references: Endocrinology. 1992 Sep;131(3):1369-76
references: 1505468